Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Advisorshares Pure Cannabis ETF (NY: YOLO )

4.050 +0.030 (+0.75%)
Streaming Delayed Price Updated: 1:05 PM EDT, May 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Advisorshares Pure Cannabis ETF

< Previous 1 2 3 4 Next >
Cannabis Stocks And ETFs Surged On Marijuana Rescheduling News: WTR's Industry Report Analyzes What's Behind The Optimism
DOJ proposes reclassifying cannabis to Schedule III. WTR's report highlights market gains and potential industry impacts. Read insights now! 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
Biden Announces 'Monumental' Marijuana Rescheduling, DOJ To Take Next Steps
Biden announces plan to reclassify marijuana from Schedule I to III, reversing inequities and removing barriers for Americans. Cannabis stocks rise. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Retreat On New Rescheduling Order Developments: What's Going On?
The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits alongside heroin and LSD, but new reports suggest the proposal has... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decision to align its stance with a recommendation from the Department of Health and... 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
What's Going On With Cannabis Stocks Wednesday?
On Tuesday, cannabis stocks fell in early trading before rebounding and trending higher in the afternoon. Some of the upward momentum may have been a result of executive commentary from the Benzinga... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
EXCLUSIVE: Florida On Cusp Of Adult-Use Legalization Cannabis Sales Boom, CEO Tells Benzinga Conference — 'It's Going To Be Huge'
'Florida has a million medical card holders, 23 million people living in the state, 130 million visitors a year — it's going to be huge,' says AYR Wellness CEO David Goubert. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Eclipsing Prohibition: US Cannabis Industry Report Shows Growth Amid Regulatory Anticipation
Explore key cannabis industry trends, ETF shifts, and regulatory anticipations with expert Jesse Redmond. Insights on AYR Wellness & more. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
There Is No Comparison Between These 9 Cannabis ETFs
This article discusses the cannabis industry and the 9 cannabis ETFs that are available. 
Via Talk Markets
Topics Cannabis ETFs
Exposures Cannabis
Cannabis Stocks And ETFs Trading Higher As Government Recommendations Ignite Hope For Industry
Cannabis stocks and ETFs opened higher on Tuesday following the release of documents related to the Department of Health and Human Service's (HHS) review of cannabis. Investors are optimistic about... 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
Canopy Growth: What Next For The Vulnerable CGC Stock?
Canopy Growth shares have crashed hard in 2023. 
Via Talk Markets
Big Tobacco Investments Drive Cannabis Stock Surge As US Equities Outshine Canadian Peers
The landscape of cannabis stocks is undergoing a significant shift, with recent weeks marking a robust uptick in market performance. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Cash Burn Concerns? Sell These 7 Overbought Stocks Now.
These overbought cannabis stocks are teetring on the edge as the sector is navigating through uncharted waters. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Cannabis Stocks: Why Tomorrow Might Be Too Late To Invest And How To Pick The Right Stocks
Discover profitable insights into the cannabis stock market with Benzinga PotProfits. Led by expert Michael Berger, navigate the green wave of investment opportunities today! 
Via Benzinga
Topics Cannabis
Exposures Cannabis
EXCLUSIVE: What's Next For Cannabis? Industry Experts Discuss Game-Changing New Policies
Cannabis reform has moved one step closer to reality at the federal level on Wednesday, with the Senate Banking Committee approving the Secure and Fair Enforcement Regulation (SAFER) Banking Act. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Etfs Soar On Hopes Of Federal Legalization
Marijuana stocks have been surging following a proposal by the Drug Enforcement Agency (“DEA”) to reclassify cannabis as a substance with reduced risk, fueling anticipation of federal legalization. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
From Coast To Coast: Denver's Cannabis Bus, Maryland's Weed Market Pulls In $85M In 1st Month & More
Denver Approves First Cannabis Consumption Bus Alisha Gallegos' cannabis consumption bus was licensed by the City and County of Denver, allowing it to cater to weddings, private events and festivals... 
Via Benzinga
VA And DoD Face Criticism From Rep. Blumenauer Over 'Misguided' Denial Of PTSD Treatment With Medical Cannabis
In an urgent appeal to rethink current medical marijuana policies, Rep. Earl Blumenauer (D-OR), has criticized the U.S. 
Via Benzinga
Federal Jobs Would No Longer Be Off-Limits For Marijuana Users Under New Bipartisan Push
A bipartisan duo of lawmakers seeks to end a discriminatory practice of disqualifying those who apply for federal jobs or receive security clearance for past or present cannabis use. 
Via Benzinga
These 2 Pot Stocks Are Up Big in 2023. Here's Why
Scotts Miracle-Gro and TerrAscend have disciplined plans toward growth. 
Via The Motley Fool
3 Cannabis Stocks With Double-Digit Percentage Revenue Growth
Their shares may be down, but their sales are up. 
Via The Motley Fool
2 Cannabis Stocks on the Rise With Next to No Competition
These cannabis real estate investment trusts are growing. 
Via The Motley Fool
Cannabis Producer Ianthus Capital Explores Options For A Potential Sale Following Rough Year
Cannabis company iAnthus Capital Holdings Inc. (OTCPK: ITHUF) is evaluating a potential sale with a consultant, according to sources familiar with the matter, 
Via Benzinga
What Makes Upside Potential For Hexo? Analyst Explains On Heels Of The Deal Break With Molson Coors
Year-to-date, Hexo (NASDAQ: HEXO) shares lost 77.15%, compared to AdvisorShares Pure Cannabis ETF (NYSEARCA: YOLO) which went down 61.12%, and AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), which... 
Via Benzinga
Election Results And Marijuana: What Happened With Weed In Arkansas, Maryland, Missouri, North Dakota & South Dakota?
On Tuesday, citizens in five (mostly red) states voted on whether or not to legalize cannabis for adult use. 
Via Benzinga
Forget About SAFE Plus Or CLIMB Act As Cannabis Stock Catalysts, With Canopy's Potential Exception
Canopy Growth Corporation (NASDAQ: CGC)  
Via Benzinga
Mostly Tricks, Few Treats For Pot Stocks in 2022
Halloween is prime spooky season, but for most investors, all of 2022 has been quite scary. Stocks across the board have taken substantial hits this year, with cannabis particularly affected. Cannabis'... 
Via Benzinga
3 Under-the-Radar Cannabis Stocks to Buy Right Now
Three cannabis stocks are getting overlooked despite strong performances. 
Via The Motley Fool
Why Green Thumb's Rise Could Carry Through 2023
The company's planned partnership with Circle K convenience stores in Florida is one of several reasons Green Thumb has a bright future. 
Via The Motley Fool
Cannabis ETFs Trending Up To Start Q4
Here are five cannabis ETFs that have been leading the way higher over the past week and will likely continue doing so. 
Via Talk Markets
2 of the Best Buys Among Cannabis Stocks Right Now
These companies' shares are down, but their revenue is on the upswing, both sequentially and year over year. 
Via The Motley Fool
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.